Table 13.
Level of control | Ideal (non‐diabetes) | Appropriate | Inappropriate (intervention suggested) | High risk (intervention required) |
---|---|---|---|---|
Clinical evaluation | ||||
Hyperglycemia | Not present | Asymptomatic | Polydipsia, polyuria and/or enuresis | Visual impairment, poor weight gain, growth impairment, late puberty, poor school attendance, skin or pudendal infection, and/or angiopathy |
Hypoglycemia | Not present | No severe hypoglycemia | Severe hypoglycemia (impaired consciousness, convulsion) | |
Biochemical evaluation | ||||
SMBG value (mg/dL) | ||||
Early morning/preprandial value | 65–100 | 90–145 | >145 | >162 |
PG* value (mg/dL) | ||||
PPG** | 80–126 | 90–180 | 180–250 | >250 |
Bedtime PG | 80–100 | 120–180 | <120 or 180–200 | <80 or >200 |
Nighttime PG | 65–100 | <80–161 | <75 or >162 | <70 or >200 |
HbA1c (%) | <6.5 | <7.5 | 7.5–9.0 | >9.0 |
*PG, plasma glucose; **PPG, postprandial plasma glucose.
(1) All values given above are intended as a guide only and the glycemic control target should be determined individually to ensure it will not be associated with severe hypoglycemia or frequent mild‐to‐moderate hypoglycemia and will help achieve glycemic control as near‐normal as possible in each patient. (2) All values given above should be modified for each patient depending on whether he/she has a prior history of severe hypoglycemia or hypoglycemia unawareness. (3) PG value is given as plasma glucose value in self‐monitoring of blood glucose (SMBG). (Adapted from Rewers M et al. Pediatr Diabetes 2014 16 ).